602 results on '"Bensussan A"'
Search Results
2. ADVANCES IN NON-RESPONSIVE AND REFRACTORY CELIAC DISEASE
3. “Co-encapsulation of Immunosuppressive Drug with Anti-inflammatory Molecule in Pickering Emulsions as a Novel Therapeutic Approach for Inflammatory Dermatoses”
4. CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas
5. Can Psyllium Alleviate Colitis?
6. Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy
7. Exploring the non-lymphocytic cutaneous microenvironment in advanced cutaneous T-cell lymphomas using single-cell RNA-sequencing
8. Generation of induced pluripotent stem cells (iPSCs) from a microvillus inclusion disease patient with a homozygous missense mutation in UNC45A
9. CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas
10. Can Psyllium Alleviate Colitis?
11. Intestinal immunoregulation: lessons from human mendelian diseases
12. The Promise of Novel Therapies to Abolish Gluten Immunogenicity in Celiac Disease
13. 621 Heterogeneity: a new insight in deciphering keloid physiopathology
14. 464 CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
15. 583 RNA sequencing of immortalised balding and non balding DPCs identifies potential balding gene signatures
16. CCR8 : nouvelle cible thérapeutique dans les lymphomes T cutanés
17. Caractérisation de l’expression du CD39 dans les lymphomes T cutanés primitifs
18. Les anticorps monoclonaux chimériques anti-ICOS 314.8 inhibent les cellules tumorales et les lymphocytes T régulateurs dans le syndrome de Sézary
19. Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract
20. Distinction between CTCL and inflammatory dermatoses using mRNA expression of cancer-associated fibroblast markers from skin biopsies
21. Characterization of CD39 expression in cutaneous T cell lymphomas
22. CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
23. Chimerized anti-ICOS 314.8 monoclonal antibodies inhibit tumor cells and regulatory T cells in patients with Sézary syndrome
24. Early detection of relapse in Sézary syndrome: the added value of KIR3DL2, T-plastin, Twist and Tox for clinical routine
25. Maladie cœliaque : de la pathogénie aux perspectives thérapeutiques
26. Intoxication volontaire à la flecaïnide : évolution, complications et prise en charge
27. Les anticorps monoclonaux chimériques anti-ICOS 314.8 inhibent les cellules tumorales et les lymphocytes T régulateurs dans le syndrome de Sézary
28. CCR8 : nouvelle cible thérapeutique dans les lymphomes T cutanés
29. Impact of transcatheter edge-to-edge mitral valve repair on right ventricular function
30. Maladie cœliaque : de la pathogénie aux perspectives thérapeutiques
31. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
32. 621 Heterogeneity: a new insight in deciphering keloid physiopathology
33. 464 CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
34. 583 RNA sequencing of immortalised balding and non balding DPCs identifies potential balding gene signatures
35. Caractérisation de l’expression du CD39 dans les lymphomes T cutanés primitifs
36. Diminution des forces mécaniques des fibroblastes du derme humain avec l’âge
37. Les variants bi-alléliques d’IPO8 entraînent une dysplasie du tissu conjonctif avec anomalies cardiovasculaires, squelettiques et une dérégulation immunitaire
38. A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings
39. ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells
40. Secretomic and proteomic analysis of cutaneous T cell lymphoma-associated fibroblasts
41. Quantifying response to various treatments using the revisited blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker
42. 366 Role of calcium ions released by a calcium alginate dressing on NK cell activation
43. Anti-tumor effect of anti-apoptosis clone 11 protein-derived peptides on Sézary syndrome malignant CD4+ T lymphocytes
44. Exploring the role of the skin microenvironment in cutaneous T-cell lymphoma using single cell RNA-sequencing
45. 198 Il-33 is a central mediator of necroptosis-induced skin inflammation
46. 238 Modulation of the antigen presentation capacity of Langerhans cells by a Pickering emulsion combining an immunosuppressive and an anti-inflammatory drug
47. 364 Mechanical forces of human dermal fibroblasts significantly decrease with age
48. CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
49. Early detection of relapse in Sézary syndrome: the added value of KIR3DL2, T-plastin, Twist and Tox for clinical routine
50. Distinction between CTCL and inflammatory dermatoses using mRNA expression of cancer-associated fibroblast markers from skin biopsies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.